Alkem Laboratories Ltd
http://alkemlabs.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Alkem Laboratories Ltd
Can Roche’s Phesgo Mirror UK Adoption Trend in India?
Roche debuts ‘responsibly priced’ Phesgo in India. Will the dramatic reduction in treatment time for women with HER2 positive breast cancer and other benefits, including insurance coverage, trigger sharp shifts towards the subcutaneous fixed-dose combination of Perjeta and Herceptin?
Alkem Sees Nearly 20% Growth Domestically
India’s Alkem has delivered another healthy quarter as the company continues to perform domestically. However, the company’s US sales continues to be under pressure despite new launches.
Voluntary Limits On Antibacterial Discharges Increase As Fear Of Resistance Grows
Pharmaceutical companies are ratcheting up voluntary efforts to control discharges of antimicrobials from their plants and those of their active pharmaceutical ingredient suppliers so they won’t contribute to antimicrobial resistance. But will it be enough to fend off regulation in countries like India?
Alkem Delivers Strong Quarter With Domestic Recovery
India’s Alkem has delivered a strong quarter with a boost in its domestic business on the back of “strong volume-led growth in the acute therapies and faster than market growth in chronic therapies.” However, the company saw a slight YoY decline in the US.
Company Information
- Industry
- Pharmaceuticals